Carbamazepine Tablets USP, 200 mg have an estimated market size of $32 million for 12 months ending December 2024, according ...

Alembic Limited ( ($IN:ALEMBICLTD) ) has issued an announcement. Alembic Limited announced a change in the email and website address of its ...

Alembic Pharmaceuticals receives USFDA approval to market Carbamazepine tablets (200mg) in the US. The generic drug is ...

Alembic Pharmaceuticals Limited on April 17, 2025, informed that it has received final approval from the US Food & Drug ...

Alembic Pharmaceuticals manufactures Indian formulations, active pharmaceutical ingredients (APIs), and international ...

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbamazepine Tablets USP ...

Alembic Pharmaceuticals announced that it has received final approval from the U.S. Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Carbamazepine Tablets USP, ...

Alembic, operating in the Realty sector and classified as a Smallcap on the BSE, currently has its share price at ₹103.83. The stock has experienced fluctuations today, with a low of ₹103.02 ...

(MENAFN- Adfactors PR) 24th March, 2025, Bengaluru:Alembic Pharmaceuticals today announced that it has successfully completed the United States Food and Drug Administration (USFDA) inspection for ...

Alembic Ltd share price was down by -5.68% from the previous closing price of ₹107.71. Who are peers of Alembic Ltd? The peers of Alembic Ltd are DLF Ltd, Macrotech Developers Ltd, Godrej ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.